Riffa Pharmaceuticals Private Limited
About Riffa Pharmaceuticals Private Limited
Data last updated:
Riffa Pharmaceuticals Private Limited is a private limited company based in Gaya, Bihar, India. It operates in the other hospital and medical care activities segment of the healthcare sector. It was incorporated on 14 May 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Patna, under CIN U74999BR2016PTC031559. The company has 1 GST registration on record, which is no longer active.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors including Saba Nazim (Whole-Time Director) and Md Amir Ali Khan.
Its last annual general meeting (AGM) was held on 30 September 2017, and its latest financial statements are for the year ended 31 March 2017. The registered office is at H. No. 16 Vill. – Rukunpur Po. – Guraru, Gaya, Bihar, India – 824118.
As per the financials filed for FY 2017, the company reported a revenue of ₹8.39 Lakh. For the same year it recorded a net loss of ₹3.25 Lakh (net margin -38.7%) and EBITDA of -₹3.12 Lakh (EBITDA margin -37.2%).
The current compliance status is marked as active non-compliant by the Registrar of Companies.
Company details
Contact details
Riffa Pharmaceuticals Private Limited's registered office is in Gaya, Bihar. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressH. No. 16 Vill. – Rukunpur Po. – Guraru, Gaya, Bihar, India – 824118
- IndustryHealthcare, Other Hospital And Medical Care Activities
To see the full contact details of Riffa Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Riffa Pharmaceuticals is hospital and medical care. In detail, this covers other hospital and medical care activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q6 | Other Hospital and Medical Care Activities |
To see the full business activity and turnover split of Riffa Pharmaceuticals Private Limited, buy the company report.
Financials of Riffa Pharmaceuticals Private Limited
FY 2017 filings availableRiffa Pharmaceuticals Private Limited reported revenue of ₹8.39 Lakh for FY 2017.
Financial Statement Summary
| Metrics | FY 2016-17 |
|---|---|
| Profit and Loss Statement | |
| Revenue from Operations | ₹8.39 Lakh |
| Other Income | |
| Total Revenue | |
| Cost of Materials Consumed | |
| Employee Benefit Expense | |
| Finance Costs | |
| Depreciation and Amortisation | |
| Other Expenses | |
| Total Expenses | |
| EBITDA | -₹3.12 Lakh |
| Profit Before Tax | |
| Tax Expense | |
| Net Profit (PAT) | -₹3.25 Lakh |
| Balance Sheet | |
| Share Capital | |
| Reserves and Surplus | |
| Net Worth (Total Equity) | |
| Long-term Borrowings | |
| Short-term Borrowings | |
| Trade Payables | |
| Total Liabilities | |
| Fixed Assets | |
| Investments | |
| Inventories | |
| Trade Receivables | |
| Cash and Bank Balance | |
| Total Assets | |
Financial Ratios
| Metrics | FY 2016-17 |
|---|---|
| Profitability | |
| EBITDA Margin | -37.2% |
| Net Profit Margin | -38.7% |
| Return on Equity (ROE) | |
| Return on Capital Employed (ROCE) | |
| Return on Assets (ROA) | |
| Liquidity and Debt | |
| Current Ratio | |
| Quick Ratio | |
| Debt-to-Equity Ratio | |
| Interest Coverage Ratio | |
| Efficiency and Growth | |
| Asset Turnover | |
| Receivable Days | |
| Payable Days | |
| Inventory Days | |
| Revenue Growth | |
| Net Profit Growth | |
To see the full financial statements and ratios of Riffa Pharmaceuticals Private Limited, buy the company report.
Board of directors of Riffa Pharmaceuticals Private Limited
Riffa Pharmaceuticals has 3 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Saba Nazim Also directs: Splenius Global Private Limited | Whole-Time Director | 20 Jul 2020 | 6 Years 3 Months | Current |
| Md Amir Ali Khan | Director | 29 Jul 2020 | 6 Years 3 Months | Current |
| Rambadan Paswan | Director | 14 May 2016 | 10 Years 6 Months | Current |
Auditor
Riffa Pharmaceuticals Private Limited is audited by DIPAK KUMAR for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| DIPAK KUMAR | FY 2017 | 542404 |
Shareholding
The shareholding of Riffa Pharmaceuticals Private Limited is on record for FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Foreign institutional investors (FII) | |
| Public | |
| Others |
To see the full shareholding pattern of Riffa Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Riffa Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Riffa Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Riffa Pharmaceuticals has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Riffa Pharmaceuticals Private Limited, buy the company report.
Recent activity
Riffa Pharmaceuticals Private Limited has 6 board changes on record since 2016: 3 appointments and 3 cessations. The latest: Md Amir Ali Khan was appointed as Director on 29 Jul 2020.
Frequently asked questions
Riffa Pharmaceuticals is an active private limited company based in Gaya, Bihar, India. The company works in other hospital and medical care activities, within the healthcare industry. It was incorporated on 14 May 2016 (10+ years old) and is registered under CIN U74999BR2016PTC031559.
Riffa Pharmaceuticals has 3 current directors:
- Saba Nazim - Whole-Time Director
- Md Amir Ali Khan - Director
- Rambadan Paswan - Director
The latest financial statements of Riffa Pharmaceuticals on record with the MCA are for the year ended 31 March 2017. Its last annual general meeting was held on 30 September 2017. Year-wise statements from FY 2017 are in the company report.
No. Riffa Pharmaceuticals has 1 GST registration on record and it is cancelled or inactive.
The CIN (Corporate Identification Number) of Riffa Pharmaceuticals is U74999BR2016PTC031559. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Riffa Pharmaceuticals was incorporated on 14 May 2016, making it 10+ years old. It is registered with the Registrar of Companies, Patna.
Md Amir Ali Khan was appointed as Director on 29 Jul 2020. Mohammad Fahad Khan Rayees ceased to be Director on 29 Jul 2020. Rais Ahmad Khan ceased to be Director on 20 Jul 2020. Riffa Pharmaceuticals has 6 board changes on record in total.
The registered office of Riffa Pharmaceuticals is at H. No. 16 Vill. – Rukunpur Po. – Guraru, Gaya, Bihar, India – 824118.
Riffa Pharmaceuticals operates in the healthcare industry, in the other hospital and medical care activities segment.
The compliance status of Riffa Pharmaceuticals is active non-compliant as of 20 September 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
